Pharmacoeconomic Study of First-Line Perindopril/Indapamide Combination in Lowering Blood Pressure and Reducing Albuminuria
- 1 January 2005
- journal article
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 12 (4) , 203-213
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effect of Low-Dose Perindopril/Indapamide on Albuminuria in DiabetesHypertension, 2003
- Does Microalbuminuria Predict Diabetic Nephropathy?Diabetes Care, 2002
- Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive PatientHypertension, 2001
- Pharmacoeconomics of Hypertension ManagementPharmacoEconomics, 2001
- Pharmacoeconomics and Health PolicyPharmacoEconomics, 1999
- HypertensionDisease Management and Health Outcomes, 1997
- Cost-effectiveness analysis of hypertension treatment — A review of methodological issuesHealth Policy, 1991
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Therapeutic trials and large arteries in hypertensionAmerican Heart Journal, 1988
- Allocation of Resources to Manage HypertensionNew England Journal of Medicine, 1977